Literature DB >> 76795

Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.

M K Ward, T G Feest, H A Ellis, I S Parkinson, D N Kerr.   

Abstract

In patients maintained on regular haemodialysis in Newcastle upon Tyne the development of osteomalacia is substantially reduced when water used to prepare dialysate is deionised. After 1--4 years of dialysis, osteomalacia was evident in 15% of patients on deionised water in 70% of patients on softened water from the same source. The close association of dialysis encephalopathy and osteomalacia suggests a common aetiology. Both diseases occur in centres with a high tap-water aluminium content. Serum-aluminium concentrations were raised in patients undergoing regular haemodialysis in the Northern Region of England. Those using softened water had higher concentrations than those using deionised water. Patients on softened water who had encephalopathy or dementia had serum-aluminium concentrations similar to those of patients using the same water-supplies without symptoms of these diseases, but they had been treated for longer. The evidence that aluminium absorption from dialysate causes osteomalacia and encephalopathy is strong enough to justify the expense of treating water by deionisation, reverse osmosis, or both in centres where tap-water aluminium is high.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76795     DOI: 10.1016/s0140-6736(78)90191-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  47 in total

1.  Comparative binding study of aluminum and chromium to human transferrin. Effect of iron.

Authors:  A A Moshtaghie; M Ani; M R Bazrafshan
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

2.  Aluminum transport and dialysance during haemodialysis.

Authors:  S Hosokawa; H Nishitani; T Nishio; T Imai; Y Tomita; T Tomoyoshi; K Sawanishi; O Yoshida
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

3.  Aluminum and the pathogenesis of dialysis dementia.

Authors:  A I Arieff
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

4.  Induction of de novo bone formation in the beagle. A novel effect of aluminum.

Authors:  L D Quarles; H J Gitelman; M K Drezner
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

5.  The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls.

Authors:  Hans-Olov Hellström; Bengt Mjöberg; Hans Mallmin; Karl Michaëlsson
Journal:  Osteoporos Int       Date:  2005-07-27       Impact factor: 4.507

Review 6.  Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods.

Authors:  Daniela Fanni; Rossano Ambu; Clara Gerosa; Sonia Nemolato; Nicoletta Iacovidou; Peter Van Eyken; Vassilios Fanos; Marco Zaffanello; Gavino Faa
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

7.  Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.

Authors:  C R Dunstan; R A Evans; E Hills; S Y Wong; A C Alfrey
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

8.  Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride.

Authors:  K H Lau; A Yoo; S P Wang
Journal:  Mol Cell Biochem       Date:  1991-07-10       Impact factor: 3.396

9.  Quantitative bone histology in 38 patients with advanced renal failure.

Authors:  J B Eastwood
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

10.  Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.

Authors:  A A O'Brien; D P Moore; J A Keogh
Journal:  Ir J Med Sci       Date:  1990-03       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.